NFKB1 and non-small cell lung carcinoma: Some studies focusing on non-threatening illnesses have indicated that TRIM21 stimulates p65, leading to the activation of the NF-κB signaling pathway and the onset of an inflammatory reaction.23, 24, 25 However, whether TRIM21 can regulate the NF-κB signaling pathway in NSCLC has not been reported.